Online ISSN: 1949-2553
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

Genetic Insights into Early Breast Cancer in Kazakhstan

Oncotarget

October 5, 2023
In this new study, researchers aimed to determine the genetic predisposition to early breast cancer in women from Kazakhstan. continue reading »

UGDH in Clinical Oncology and Cancer Biology

News

October 4, 2023
PRESS RELEASE: On September 28, 2023, a new review was published in Oncotarget, entitled, “UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology.” continue reading »

An Ancient Anti-cancer Mechanism: DISE

News

October 3, 2023
PRESS RELEASE: On September 25, 2023, a new editorial was published in Oncotarget, entitled, “DISE, an ancient anti-cancer mechanism that senses mutational load in cancerous cells?” continue reading »

Reassessing COVID-19 Precautions in 2023

News

September 27, 2023
PRESS RELEASE: On September 22, 2023, a new editorial was published in Oncotarget, entitled, “Reassessing the risks and benefits of COVID-19 precautions in 2023.” continue reading »

Four Novel Receptors May Link Endometrial Cancer to PCOS

News

September 25, 2023
On September 22, 2023, a new research paper was published in Oncotarget, entitled, “Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas.” continue reading »